Fig. 2
Comparison of infliximab durability between monotherapy and combination therapy groups (Kaplan–Meier survival curves, p = 0.0026).
Fig. 2 | Scientific Reports
Comparison of infliximab durability between monotherapy and combination therapy groups (Kaplan–Meier survival curves, p = 0.0026).
